Navigation Links
Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped
Date:7/23/2014

tioned that the phase 3 trial data from Vertex has not yet gone through the peer-review process typically required to give physicians confidence in the results.

An earlier, phase 2 trial -- also with positive results for patients -- was published online in the peer-reviewed journal The Lancet Respiratory Medicine in June.

Cystic fibrosis affects an estimated 30,000 people in the United States, according to the Cystic Fibrosis Foundation. It's an inherited disease that disrupts cells in the lungs and the pancreas, causing mucus to become thick and sticky. The mucus builds up, causing breathing and digestion problems.

"Existing medications target only the symptoms of cystic fibrosis but not the cause of the disease," Gentzsch said. "As a result, they may lead to improvement but do not prevent the overall slow progression of lung disease over time. In addition, many current therapies are time-consuming and can be more difficult to use in young children."

A newer drug known by the brand name Kalydeco targets a protein that doesn't work properly in certain people with cystic fibrosis. Researchers have praised the medication, but it only works in an estimated 5 percent of patients who have a specific genetic variation.

The big question is whether Kalydeco and a drug that's in development known as lumacaftor might provide a one-two punch to treat the wide majority of cystic fibrosis patients. If the combo worked, as some short-term studies have suggested, "the hope would be that disease progression would be slowed and that patients would live longer, healthier lives," Gentzsch said.

But the new study raises doubts. The researchers tested the drugs on epithelial cells, which are found in much of the body, and found evidence that Kalydeco actually reverses some of the effects of lumacaftor. "This is consistent with results reported from recent clinical trials that showed meaningful but modest improvements in lung function in patien
'/>"/>

Copyright©2014 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cystic Fibrosis Market Sales to Grow $5.3 Billion with 28.96% CAGR to 2018 Says a New Report Available at ReportsnReports.com
2. Cystic fibrosis and diabetes link explained
3. Ataluren Phase 3 trial results in nonsense mutation cystic fibrosis
4. 26 Year-old Biotech Headhunter with Cystic Fibrosis, Selected as One of “San Diego’s Finest” - Training for First Run Martathon to Benefit The Cystic Fibrosis Foundation
5. Thyroid project sheds light on molecular processes related to cystic fibrosis
6. Childrens National researcher co-authors study on transitioning cystic fibrosis care
7. Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis
8. ChanTest Announces a Global Campaign to Share New Findings and Developments in Cystic Fibrosis Research
9. ChanTest Announces ChansPorter™ Assays to Accelerate Drug Development for Cystic Fibrosis Patients
10. Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis
11. Drug combination promotes weight loss in polycystic ovary syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped
(Date:5/28/2015)... San Francisco,CA (PRWEB) May 28, 2015 ... to creating technology that advances sexual health and ... that the University of San Francisco (USF) will ... online college sexual assault recording and reporting system. ... more empowering, transparent, and confidential reporting experience for ...
(Date:5/28/2015)... May 28, 2015 lifeIMAGE ... round of financing led by Cambia Health Solutions ... dedicated to transforming health care by creating a person-focused ... most utilized network for exchanging medical imaging, will use ... base, increase the breadth of its network capabilities and ...
(Date:5/28/2015)... Optimity Advisors ( Optimity ) ... of care for healthcare organizations worldwide – today ... help operationalize contracting and engagement models. As part ... series of seven “ OrangePapers” that provide ... is a strategy, operations and information technology advisory ...
(Date:5/28/2015)... 28, 2015 WebWatcher, the ... their partnership with BeSure Consulting to help ... The partnership will combine BeSure Consulting’s ... parental monitoring software solution. , Led by ... Consulting's passion is concentrated on teaching law ...
(Date:5/28/2015)... Cancer survivors who participated in the LIVESTRONG ... fitness and quality of life, according to research conducted ... Jennifer Ligibel, MD, senior physician in the Susan F. ... The findings will be presented at this year’s ... in Chicago. , The study, designed to ...
Breaking Medicine News(10 mins):Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4
... Nov. 3 The Guardian Life Insurance Company ... benefit enrollment,services by adding more features to serve ... Census Bureau, Spanish speakers constitute 12,percent of the ... has introduced customized Spanish-language benefit enrollment,kits, with everything ...
... Genoveva (“Gigi”) Garcia, a 91-year-old movie buff who once was a ... final reel in her life has a surprising twist: Her granddaughter, ... sharing her riches-to-rags-to-riches story with others on CarePages.com, a community of ... , ...
... 3 Paul Offit, MD,announced today that all author ... False Prophets: Bad Science, Risky Medicine, and the Search,for ... Autism Research at,Children,s Hospital of Philadelphia., (Photo: ... with Dr. Offit, and to accept the,royalties of his ...
... scientists have discovered a mechanism by which intracellular pathogens ... weapons against them: nitric oxide. The researchers found that ... biochemical machinery used by immune cells called macrophages to ... tanks of the immune system, attacking and consuming bacteria ...
... in detecting airway stent complications according to a recent ... Harvard Medical School in Boston, MA. , MDCT ... patients, including all cases of intraluminal narrowing, migration, invasion ... of four cases of stent fracture," according to Vandana ...
... or surgical procedures for children with suspected musculoskeletal ... study performed at Vanderbilt Children,s Hospital in Nashville, ... on 130 children with suspected musculoskeletal infections; 34 ... after diagnostic or therapeutic intervention and 96 patients ...
Cached Medicine News:Health News:Guardian Enhances Enrollment Capabilities With More Spanish Language Services 2Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 2Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 3Health News:Author Royalties From Autism Book Donated to Autism Research 2Health News:Parasites that live inside cells use loophole to thwart immune system 2Health News:Parasites that live inside cells use loophole to thwart immune system 3
(Date:5/28/2015)... Calif. , May 28, 2015  Based ... market, Frost & Sullivan recognizes Lexmark Healthcare ... Sullivan Award for Company of the Year in ... take HCM to the next level of interoperability ... acquisitions and followed them up with large-scale product ...
(Date:5/28/2015)... , May 26, 2015 Research ... of the "2015 Strategies in the US ... Market" report to their offering. ... provides comprehensive analysis of the diagnostic testing markets ... ICUs). The report includes analysis of the market ...
(Date:5/28/2015)... -- Cypher Genomics, Inc., the leading genome ... announced a collaboration in which Cypher,s automated genomic interpretation ... genetic diseases among a unique population. Located in ... Children (CSC) serves many Amish and Mennonite patients, a ... disease. "We are very excited to ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 2Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 3
... -- BERGISCH GLADBACH, Germany, September 22, 2010 ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r in ...
... With a company rank on this year,s list ... list of companies who have surpassed expectations during ... (Logo: http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) (Logo: ... List honors the fastest growing private companies in ...
Cached Medicine Technology:Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 2Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 3Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 4Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 5Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 6
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
This single lamp light source is perfect for surgeon's offices, cath labs, dermatology offices, and specialty uses....
Delivers one primary lamp and one backup lamp. The port accepts ACMI fiberoptic cables....
The 300W effective dual light source has quality xenon performance....
Medicine Products: